Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico

Annals of Hepatology

Volumn 9, Issue 1, 2010, Pages 33-39

  Jimenez Mendez, Ricardo ^a   Uribe Salas, Felipe ^b   López Guillen, Paulo ^b   Cisneros Garza, Laura ^b   Castañeda Hernandez, Gilberto ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Burden of disease; Chronic hepatitis; Geographic; Infected carriers; Pharmaco epidemiology

Indexed keywords

VIRUS RNA;

ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; MIXED INFECTION; PREVALENCE; VIRUS CARRIER; VIRUS LOAD; BLOOD; COMPARATIVE STUDY; GENETICS; HETEROZYGOTE; RETROSPECTIVE STUDY;

FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HETEROZYGOTE; HUMANS; MALE; MEXICO; PREVALENCE; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 77954578186     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31676-x     Document Type: Article

References (24)

1. Flamm SL. Chronic hepatitis C virus infection. JAMA 2003; 289: 2413-17.
2. Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97-102.
3. Kirosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-75.
4. Simmonds P. Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 2004; 85: 3173-88.
5. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 2005; 10: 1-11.
6. Jensen DM, Morgan TR, Marcellin P, Pockros TJ, Reddy KR, Hadziyannis SJ, Ferenci P, et al. Early identification of HCV genotype 1 patients responding to 24 weeks pegin-terferon?-2a 40 kd)/ribavirin therapy. Hepatology 2006; 43: 954-60.
7. Chevaliez S, Pawlotsky JM. Interferon-based therapy of hepatitis C. Adv Drug Deliv Rev 2007; 59: 1222-41.
8. Smith DB, Pathirana S, Davison F, Lawlor E, Power J, Lee Yap P, Simmonds P. The origin of hepatitis C virus genotypes. J Gen Virol 1997; 78: 321-8.
9. Pawlotsky JM, Tsakiris JM, Roudotthoraval F, Pallet C, Stu-yver L, Duval J, Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171: 1607-10.
10. Sánchez-Ávila JF, González E, Vázquez V, Suárez S, Uribe M. Geographical distribution of HCV genotypes in Mexico. Ann Hepatol 2007; 6: 156-60.
11. Aral SO, Holmes KK. Advances in multilevel approaches to understanding the epidemiology and prevention of sexually transmitted infections and HIV: an overview. J Infect Dis 2005; 191(Suppl. 1): S1-6.
12. Bassols A. Economic Geography of Mexico: Theory, General Phenomena, Regional Analysis (in Spanish). Mexico City, México: Trillas; 1980.
13. Méndez-Sánchez N, Motola-Kuba D, Zamora-Valdés D, Sán-chez-Lara K, Ponciano-Rodríguez G, Uribe-Ramos MH, Váz-quez-Fernández F, et al. Risk factors and prevalence of hepatitis virus B and C serum markers among nurses at a tertiary-care hospital in Mexico City: a descriptive study. Ann Hepatol 2006; 5: 276-80.
14. Benitez-Arvizu G, Cortéz-Gómez R, Novelo-Garza BA, Mala-gón-Martínez A, Guerra-Márquez A, AlvaradMaldonado M ,del C, Rodríguez-Bartolo M, et al. Prevalence of hepatitis C virus in the blood bank at Centro Médico Nacional la Raza (in Spanish). Rev Med Inst Mex Seguro Soc 2006; 44: 227.
15. García-Montalvo BM, Macossay-Castillo M. Preliminary data for genotype distribution and epidemiological aspects of hepatitis C virus infection in blood donors from Yuca-tán, Mexico. Transfus Med 2007; 17: 488-90.
16. Rivas-Estilla AM, Cordero-Pérez P, Trujillo-Murillo K ,de C, Ramos-Jiménez J, Chen-López C, Garza-Rodríguez M ,de L,Ramírez-Gutiérrez A, et al. Genotyping of hepatitis C virus (HCV) in infected patients form Northeast Mexico. Ann Hepatol 2008; 7: 144-7.
17. Santos-López G, Sosa-Jurado F, Vallejo-Ruiz V, Meléndez-Mena D, Reyes-Leyva J. Prevalence of hepatitis C: a systematic review. J Infection 2008; 56: 282-90.
18. Chiquete E, Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico. Intervirology 2007; 50: 1-8.
19. Viazov S, Widell A, Nordenfelt E. Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 2000; 28: 21-5.
20. Seme K, Poljak M, Zuzec-Resek S, Debeljak M, Dovc P, Ko-ren S. Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron 1997; 77: 273-8.
21. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008; 8: 1-9.
22. Pawlotsky JM. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 2003; 59: 1-11.
23. Zeuzem S. Heterogeneous virologic response rates to in-terferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 2004; 140: 370-81.
24. McHutchison JG, Poynard T. Combination therapy with in-terferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis 1999; 19(Suppl. 1): 57-65.